This ebulletin contains information on regulating biocides in Northern Ireland

Having trouble viewing this email? View the content as a web page.

Health and Safety Executive logo

HSE ebulletin

Reminder - upcoming EU active substance expiry dates

Biocidal products must be phased off the NI market

The active substance/product type combinations listed below are due to expire under the EU Biocidal Products Regulation (EU BPR) on the following dates. This affects NI:

  • 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) (CAS 60207-90-1 EC 262-104-4) in product type 9 
    31 May 2025
  • Carbon dioxide (CAS 124-38-9 EC 204-696-9) in product type 15
    31 May 2025

Once the approvals expire, the active substances will no longer be able to be used in biocidal products of the relevant product types in NI.

 

In addition articles treated with such products will no longer be able to be placed on the market in NI.

 

If you hold an affected EU BPR product authorisation or Control of Pesticides Regulations (COPR) product approval, we will contact you about cancelling or revoking your authorisation or approval.

 

You will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision.

 

If you are aware of any disproportionate negative impacts that are likely to arise from the expiry of any of the active substance/product type combinations listed above, please contact us.


Reminder – upcoming EU active substance renewal submission deadlines

Apply for active substance renewal by the deadlines to keep products on the NI market

Under the EU BPR, active substance approvals will expire unless a renewal application is submitted to ECHA at least 550 days before their expiry date.

 

The 550-day deadlines are coming up for the following active substance/product type combinations under EU BPR. This affects NI:

  • 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) (CAS 60207-90-1 EC 262-104-4) in product type 7
    29 May 2025
  • 3-iodo-2-propynylbutylcarbamate (IPBC) (CAS 55406-53-6 EC 259-627-5) in product type 13
    29 May 2025
  • 5-chloro-2-(4-chlorphenoxy)phenol (DCPP) (CAS 3380-30-1 EC 429-290-0) in product types 1, 2 and 4
    29 May 2025
  • Potassium (E,E)-hexa-2,4-dienoate (Potassium Sorbate) (CAS 24634-61-5 EC 246-376-1) in product type 8
    29 May 2025

Any person, company or task force/consortium can support an active substance/product type combination for renewal – it doesn’t have to be the original supporter. Check the EU Article 95 List to see who the original supporters were.

 

If any of these active substance/product type combinations are important to you, consider contacting your supplier to let them know.

 

If a renewal application is not submitted for the above active substance/product type combinations under EU BPR, the approvals will expire.

 

This means the active substances will no longer be able to be used in biocidal products of the relevant product types in NI.

 

In addition articles treated with such products will no longer be able to be placed on the market in NI.


Active substances no longer supported in the EU

Non-approval decisions to be taken for unsupported active substances in the EU

Following an opportunity for any person, company or task force/consortium to support the active substance/product type combinations listed below in the EU Review Programme, no compliant notifications and/or dossiers were received. This affects NI:

  • Silver adsorbed on silicon dioxide (CAS n/a EC n/a) in product type 9
  • p-[(diiodomethyl)sulphonyl]toluene (CAS 20018-09-1 EC 243-468-3) in product types 6, 7, 9 and 10

These active substance/product type combinations will now be subject to an EU non-approval decision.

 

Once a decision is taken, the active substances will no longer be able to be used in biocidal products of the relevant product types in NI.

 

In addition articles treated with such products will no longer be able to be placed on the market in NI. HSE will provide separate updates on the decision and relevant phase-out periods.

 

If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, please contact us as soon as possible.

Get latest news and updates from HSE across a range of industries and topics by subscribing to our ebulletins.

Gov.uk

Health and Safety Executive - 2.2 Redgrave Court, Merton Road, Bootle, Merseyside L20 7HS